封面
市場調查報告書
商品編碼
1741280

現實世界數據 (RWD) 市場(按組件、應用、最終用戶和地區)

Real World Data (RWD) Market, By Component, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年真實世界數據 (RWD) 市場規模估計為 23.8 億美元,預計到 2032 年將達到 61 億美元,2025 年至 2032 年的年複合成長率為 14.4%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 23.8億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年年複合成長率: 14.40% 2032年價值預測 61億美元

真實世界數據在理解和應對各行各業的複雜挑戰中發揮著至關重要的作用。它指的是從現實世界中收集的資訊,包括人口統計、經濟指標、醫療記錄和環境因素。與模擬數據或理論數據不同,全球真實世界數據 (RWD) 能夠洞察實際事件、行為和趨勢。這使得研究人員、政策制定者和企業能夠做出明智的決策,開發準確的模型並實施有效的策略。隨著先進技術的出現和大規模數據可用性的提高,全球真實世界數據 (RWD) 分析在揭示模式、識別相關性和產生可操作知識以推動創新和改善各個領域的成果方面變得越來越有價值。真實世界數據市場是指從傳統臨床試驗以外的各種來源收集和分析數據。這些資訊來源包括電子健康記錄、保險理賠資料、病患登記冊,甚至穿戴式裝置的資料。這些數據被用於醫療保健決策和策略,以改善患者治療效果並推動醫療保健產業的創新。

市場動態:

預計在預測期內,市場上新產品的不斷湧現將推動市場成長。例如,2022年11月,領先的分散式和混合式臨床試驗技術解決方案供應商Castor宣布推出旨在簡化上市後臨床試驗的新產品。憑藉其不斷擴大的全球覆蓋範圍、真實世界數據 (RWD) 的整合以及臨床試驗流程的自動化,Castor的最新產品可將臨床試驗成本降低30%,並將部署時間縮短至平均僅需四週。

然而,資料品質和完整性、資料隱私和法規遵循、資料碎片化、互通性、選擇偏差和普遍性等問題預計將在預測期內阻礙全球現實世界資料 (RWD) 市場的成長。

本研究的主要特點

  • 本報告對全球真實世界數據 (RWD) 市場進行了詳細分析,並以 2024 年為基準年,展示了預測期 (2025-2032) 的市場規模和年複合成長率。
  • 它還強調了各個領域的潛在商機,並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數,介紹了全球真實世界數據 (RWD) 市場中主要企業的概況。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員將透過用於分析全球真實世界數據 (RWD) 市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球真實世界資料 (RWD) 市場 - 冠狀病毒 (COVID-19) 疫情的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 全球真實世界數據 (RWD) 市場(按組成部分),2020 年至 2032 年

  • 服務
  • 資料集
  • 臨床環境數據
  • 帳單和索賠數據
  • 藥房數據
  • 基於註冊表的數據
  • 患者主導數據

6. 全球真實世界數據 (RWD) 市場(按應用分類),2020 年至 2032 年

  • 藥物研發與核准
  • 市場進入和報銷/覆蓋範圍確定
  • 上市後監測
  • 臨床研究
  • 其他用途

7. 全球真實世界數據 (RWD) 市場(按最終用戶分類),2020 年至 2032 年

  • 醫療保健付款人
  • 醫療保健提供者
  • 政府
  • 其他

8. 2020 年至 2032 年全球真實世界數據 (RWD) 市場(按地區)

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 南非
      • 中部非洲

第9章 競爭態勢

  • IQVIA Holdings Inc.
  • Optum, Inc.(a subsidiary of UnitedHealth Group)
  • Centre Corporation
  • Flatiron Health, Inc.
  • IBM Corporation
  • Tempus Labs Inc.
  • Syneos Health Inc.
  • Evidera, Inc.
  • Palantir Technologies Inc.
  • SAS Institute Inc.

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6029

Real World Data (RWD) Market is estimated to be valued at USD 2.38 Bn in 2025 and is expected to reach USD 6.1 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.38 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.40% 2032 Value Projection: USD 6.1 Bn

Real world data plays a crucial role in understanding and addressing complex challenges across various fields. It refers to information gathered from real-life situations, such as demographics, economic indicators, healthcare records, environmental factors, and more. Unlike simulated or theoretical data, global real world data (RWD) offers insights into actual events, behaviours and trends. It enables researchers, policymakers and businesses to make informed decisions, develop accurate models, and implement effective strategies. With the advent of advanced technologies and the growing availability of large-scale data, global real world data (RWD) analysis has become increasingly valuable in uncovering patterns, identifying correlations, and generating actionable knowledge to drive innovation and improve outcomes in diverse domains. The real-world data market refers to the collection and analysis of data from various sources outside of traditional clinical trials. These sources can include electronic health records, insurance claims data, patient registries, and even data from wearable devices. This data is then used to inform healthcare decisions and strategies, improve patient outcomes, and drive innovation in the healthcare industry.

Market Dynamics:

The increasing introduction of new products in the market is expected to drive the growth of the market over the forecast period. For instance, in November 2022, Castor, a leading provider of decentralized and hybrid clinical trial technology solutions, announced a new offering to simplify post-marketing clinical trials. By extending global reach, integrating real-world data (RWD), and automating trial processes, Castor's latest offering can reduce trial costs by 30% and deployment timelines to only 4 weeks on average.

However, data quality and completeness, data privacy and regulatory compliance, data fragmentation, and interoperability and selection bias and generalizability are expected to hamper growth of the global real world data (RWD) market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global real world data (RWD) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global real world data (RWD) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include IQVIA Holdings Inc., Optum, Inc. (a subsidiary of UnitedHealth Group), Cerner Corporation, Flatiron Health, Inc., IBM Corporation, Tempus Labs Inc., Syneos Health Inc., Evidera, Inc., Palantir Technologies Inc., SAS Institute Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The real world data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global real world data (RWD) market

Detailed Segmentation:

  • By Component:
    • Services
    • Datasets
    • Clinical settings Data
    • Claims & Billing Data
    • Pharmacy Data
    • Registry-Based Data
    • Patient-Powered Data
  • By Application:
    • Drug development and approvals
    • Market access and reimbursement/coverage decisions
    • Post-market surveillance
    • Clinical research
    • Other applications
  • By End User:
    • Pharmaceutical and medical device Companies
    • Healthcare payers
    • Healthcare providers
    • Government agencies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • IQVIA Holdings Inc.
    • Optum, Inc. (a subsidiary of UnitedHealth Group)
    • Cerner Corporation
    • Flatiron Health, Inc.
    • IBM Corporation
    • Tempus Labs Inc.
    • Syneos Health Inc.
    • Evidera, Inc.
    • Palantir Technologies Inc.
    • SAS Institute Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Real World Data (RWD) , By Component
    • Market Global Real World Data (RWD), By Application
    • Market Global Real World Data (RWD), By End user
    • Market Global Real World Data (RWD), By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Real World Data (RWD) Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Real World Data (RWD) Market, By Component, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Datasets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Clinical settings Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Claims & Billing Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pharmacy Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Registry-Based Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Patient-Powered Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Real World Data (RWD) Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Drug development and approvals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Market access and reimbursement/coverage decisions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Post-market surveillance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Clinical research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Real World Data (RWD) Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
    • Pharmaceutical and medical device Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Healthcare payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Healthcare providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Government agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Real World Data (RWD) Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • South Africa
      • Central Africa

9. Competitive Landscape

  • IQVIA Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Optum, Inc. (a subsidiary of UnitedHealth Group)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Centre Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Flatiron Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IBM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tempus Labs Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Syneos Health Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Evidera, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Palantir Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SAS Institute Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us